Article
Intermediate dosing of agent may enhance distant metastatis-free intervalfor high-risk patients
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Arcutis Submits sNDA for Roflumilast Cream 0.3% to Treat Plaque Psoriasis in Patients as Young as 2
The Cutaneous Connection: Combatting Treatment Skepticism in Advanced Pediatric Atopic Dermatitis
Examining Bond-Building Hair Care Treatments
The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition
Recognizing and Managing Pediatric Summer Skin Eruptions
Science of Skin Summit to Spotlight Breakthrough Products and Disruptive Innovations in Dermatology
How the COVID-19 Pandemic Disrupted Melanoma Diagnosis and Treatment
Equity in Melanoma Survival Masks Inequity in Diagnosis
HS TRUTHS Spotlights Hidden Patient Realities